Concourse Financial Group Securities, Inc. Cumberland Pharmaceuticals Inc Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding CPIX
# of Institutions
25Shares Held
2MCall Options Held
24.2KPut Options Held
200-
Jim Simons Renaissance Technologies LLC | New York, Ny538KShares$672,7030.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA374KShares$467,8130.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX304KShares$380,1360.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX287KShares$358,3180.01% of portfolio
-
Acadian Asset Management LLC Boston, MA188KShares$235,2050.0% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $18.3M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...